Nyracta

ATC：A10BG02

治疗领域：Diabetes Mellitus, Type 2

药理分类：Drugs used in diabetes

修订号：6 · 最新影响 PI 的程序：—

适应症（原文）：Rosiglitazone is indicated as oral monotherapy in type 2 diabetes mellitus patients, particularly overweight patients, inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance. Rosiglitazone is also indicated for oral combination treatment in type 2 diabetes mellitus patients with insufficient glycaemic control despite maximal tolerated dose of oral monotherapy with either metformin or a sulphonylurea:- in combination with metformin particularly in overweight patients.­- in combination with a sulphonylurea only in patients who show intolerance to metformin or for whom metformin is contraindicated.